Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis

This study has been completed.
Elan Pharmaceuticals
Information provided by:
Biogen Identifier:
First received: November 30, 2004
Last updated: June 17, 2009
Last verified: June 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2004
  Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)